Navigation Links
Results from trials of DHA in Alzheimer's disease and age-related cognitive decline
Date:7/11/2009

Vienna, July 12, 2009 Results from two large studies using DHA, an omega 3 fatty acid, were reported today at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna.

One of the trials was conducted by the Alzheimer's Disease Cooperative Study (ADCS) supported by the National Institute on Aging (NIA), and the second by Martek Biosciences Corporation (Martek), the primary company that makes algal DHA for supplementation. The NIA trial lasted 18 months and was conducted in people with mild to moderate Alzheimer's. Martek's trial was six months, and the compound was tested in healthy people to see its effect on "age related cognitive decline" (ARCD). Both studies used Martek's algal DHA.

The results of the ADCS trial show no evidence for benefit in the studied population. The Martek trial showed a positive result on one test of memory and learning, but that study was in healthy older adults, not people with Alzheimer's or another dementia. The results need confirmation, as is standard scientific practice.

"These two studies and other recent Alzheimer's therapy trials raise the possibility that treatments for Alzheimer's must be given very early in the disease for them to be truly effective," said William Thies, PhD, Chief Medical & Scientific Officer at the Alzheimer's Association. "For that to happen, we need to get much better at early detection and diagnosis of Alzheimer's, in order to test therapies at earlier stages of the disease and enable earlier intervention."

Other research studies from ICAD 2009 show advances made in biomarkers and early detection from the Alzheimer's Disease Neuroimaging Initiative (ADNI), and also survey results from doctors about the enablers and barriers they face in diagnosing people with Alzheimer's.

DHA (docosahexaenoic acid) is naturally found in the body in small amounts, and is the most abundant omega 3 fatty acid in the brain. DHA
'/>"/>

Contact: Niles Frantz
niles.frantz@alz.org
312-363-8782
Alzheimer's Association
Source:Eurekalert

2

GOOD

Page: 1 2 3 4

Related biology news :

1. Many parents at-risk for cancer disclose genetic test results to children
2. BIO-key Reports Second Quarter 2007 Results
3. Communication Intelligence Corporation Reports Second Quarter 2007 Financial Results
4. New CPR promises better results by compressing abdomen, not Chest
5. Positive results for airway bypass
6. 2 carotid artery stenting studies show results comparable to AHA guidelines
7. Measurement Specialties, Inc. Announces Impact of German Business Tax Reform 2008 Resulting in Lower Combined German Tax Rate - Impacts 2Q08 Reported Financial Results
8. BIO-key Reports Third Quarter 2007 Results
9. New clinical trial results show how personalized medicine will alter treatment of genetic disorders
10. Electrospray droplet research yields surprising, practical results
11. Aware, Inc. Reports Fourth Quarter and 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...009) Whitehead researchers have developed a new t...specific genes and proteins used by pathogens, acc...man cell cultures genes are present in two copies:...ther. Gene inactivation by mutation is therefore i...he second copy usually remains active and takes ov...
(Date:11/25/2009)...he stomach, may be used to boost resistance to, or...e School of Medicine researchers report in a study...uroscience . , Parkinson,s disease is caused by ...he midbrain known as the substantia nigra, which i...oduction of dopamine in late-stage Parkinson,s cau...
(Date:11/25/2009)...Soil is the linchpin of the environment, where atm...that, many students see soil as "just dirt" a pla...educators are challenged with the task of helping ...ortance of soil in the environment. , A collabo...eachers at University of Nebraska-Lincoln, Oregon ...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2Moms to Be Need Facts on Pain Control 56315 1Moms to Be Need Facts on Pain Control 56315 2TrueShred Earns Industrys Highest Security Certification 56311 1Women Urged Not to Drink While Pregnant 56308 1Women Urged Not to Drink While Pregnant 56308 2Women Urged Not to Drink While Pregnant 56308 3
...s have developed a way to synthesize a cancer-kill... learn how it works. , Derived from a fungus disco... the chemical tricks certain cancer cells into sui... 2000, scientists in Japan discovered that this co...rototype anticancer agent, but no one has been abl...
...California, San Diego (UCSD) School of Medicine sh...f liver cell death and renewal. , The research, ap...ublication in the journal Proceedings of the Natio...e of JNK1-mediated cell death and compensatory pro... professor pharmacology in UCSD¡¦s Laboratory of G...
...ubjects shows that HIV in the brain and central ne...t lives in the blood and peripheral tissues. , Mo...dy subjects was correlated with the presence of a ... The study appears in the July 2006 issue of Brain...earch associate at SFVAMC and a postdoctoral fello...
Other Biology News:New lab technique churns out fungus' potential cancer fighter 2Cycles of cell death, proliferation key to liver cancer 2Viral genetic differences are possible key to HIV dementia 2Viral genetic differences are possible key to HIV dementia 3
(Date:11/27/2009)...ire-FirstCall/ -- Stallergenes has been,granted Eu...s and children,through a Mutual Recognition Proced...as been marketed, was the reference Member state. ..., Belgium, Bulgaria, Cyprus, the,Czech Republic, E... Italy,Latvia, Lithuania, Luxembourg, Malta, the ...
(Date:11/25/2009)...re/ -- Biotech firm Replikins Ltd., which has anal...ndemic through the prediction, outbreak, and progr... latest biochemical analysis of the virus. The new... Flu") virus has dropped from its peak of 3.7 (s.d...spring of 2009 to resting non-epidemic levels this...
(Date:11/25/2009)...Newswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a l...ed today that it executed,a joint venture (JV) agr...ology Co., Ltd. (Sinovac Dalian). The JV will rese... vaccines. Sinovac will contribute its expertise,a...rld-class vaccines; the,other party will bring its...
(Date:11/24/2009)...e-FirstCall/ -- IES (Nasdaq: IESC ), a leading na...ystems and services for the commercial, industrial... commercial business group has been awarded a cont...rical systems for the Level 4 bio-safety lab (BSL-...esearch Institute of Infectious Diseases (USAMRIID...
Breaking Biology Technology:STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
... Company will Share Sneak Peek at S...al Trial , New York (PRWE...Histogen, Inc., a regenerative medicine company de...n fibroblasts grown under embryonic conditions, wi...em Cell Summit in New York. Dr. Naughton will be p...
...Feb. 14 /PRNewswire-Asia-FirstCall/ -- Yongye Biot... YGYB; "Yongye" or the "Company"), a leading devel...ants and animals, located in the People,s Republic...gement will host a conference call and webcast in ... of the Company followed by a question and answer ...
... Feb. 13 On February 10, 2009, NeoStem, Inc. (NYS...ce from the NYSE Alternext US (the "Alternext") in...h Section 704 of the Alternext Company Guide (the ...meetings of its shareholders annually. , , On No...planned to hold a shareholder meeting to obtain ap...
Other Biology Technology:Histogen to Present Preliminary Hair Regrowth Clinical Results at Stem Cell Summit 2Histogen to Present Preliminary Hair Regrowth Clinical Results at Stem Cell Summit 3Yongye Biotechnology to Host 'Virtual Retail Road Show' to Provide Overview of the Company in English and Mandarin 2Yongye Biotechnology to Host 'Virtual Retail Road Show' to Provide Overview of the Company in English and Mandarin 3Yongye Biotechnology to Host 'Virtual Retail Road Show' to Provide Overview of the Company in English and Mandarin 4NeoStem Receives Notice of Noncompliance from NYSE Alternext US 2
DNase I, RNase-free; special quality for molecular biology from Roche Applied Science
...Description: Topoisomerase I relaxes both positive...reakage and rejoining of phosphodiester bonds (1,2...allows molecules to be differentiated by a single ...somerase I is active in the absence of Mn 2+ and ...
...ning a clone of the human Topoisomerase II gene. ...gical state of nucleic acids by passing an intact ...s a separate DNA helix (1,2) . As a result of its ...can relax negatively or positively supercoiled DNA...
...yzes the template-directed polymerization of nucle...ymerase I possesses a 3?5 exonuclease activity or ...te during DNA replication, and also contains a 5?3... replace nucleotides in the growing strand of DNA ...
Biology Products: